Dr. George Dangas and Dr. C. Michael Gibson Discuss: ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation August 28, 2021 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: ESC 2021 Wrap-Up – Friday, August 27 August 27, 2021 Disclosures: TBD
Dr. Axel Bauer and Dr. Yaz Daaboul Discuss: Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction – A randomized trial August 27, 2021 Disclosures: TBD
Dr. Stefan Anker and Dr. C. Michael Gibson Discuss: EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalizations in patients with heart failure with a preserved ejection fraction, with and without diabetes August 27, 2021 Disclosures: TBD
Dr. Arnoud van ’t Hof, Dr. Jur ten Berg and Dr. C. Michael Gibson Discuss: A novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients May 18, 2021 Disclosures: TBD
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: ACC 2021 Wrap-Up – May 17, 2021 May 17, 2021 Disclosures: TBD
Dr. Robert Rosenson and Dr. C. Michael Gibson Discuss: A Phase 2 Trial Of The Efficacy And Safety Of Evinacumab In Patients With Severe Hypertriglyceridemia May 15, 2021 Disclosures: TBD
Dr. Siri Lagethon Heck and Dr. C. Michael Gibson Discuss: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol May 15, 2021 Disclosures: TBD
Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: EPA Levels and Outcomes May 15, 2021 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Relationship Between Omega-3 Fatty Acid Levels And Major Adverse Cardiovascular Outcomes In Patients With High Cardiovascular Risk May 15, 2021 Disclosures: TBD
